REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 94 filers reported holding REATA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $371,000 | -31.4% | 6,613 | 0.0% | 0.04% | -27.1% |
| Q3 2018 | $541,000 | +67.5% | 6,613 | -28.5% | 0.06% | +59.5% |
| Q2 2018 | $323,000 | +70.0% | 9,244 | 0.0% | 0.04% | +60.9% |
| Q1 2018 | $190,000 | -27.5% | 9,244 | 0.0% | 0.02% | -28.1% |
| Q4 2017 | $262,000 | -8.7% | 9,244 | 0.0% | 0.03% | -17.9% |
| Q3 2017 | $287,000 | -1.7% | 9,244 | 0.0% | 0.04% | -9.3% |
| Q2 2017 | $292,000 | +39.7% | 9,244 | 0.0% | 0.04% | +30.3% |
| Q1 2017 | $209,000 | +3.5% | 9,244 | 0.0% | 0.03% | -2.9% |
| Q4 2016 | $202,000 | +61.6% | 9,244 | +94.8% | 0.03% | +54.5% |
| Q3 2016 | $125,000 | +33.0% | 4,746 | 0.0% | 0.02% | +22.2% |
| Q2 2016 | $94,000 | – | 4,746 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
| Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
| Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
| Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
| Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
| KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
| Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
| MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
| Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |